Citations (5)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Haonan Zhang, Haijun Zhang & Hai Fang. (2024) Cost-effectiveness analysis of vaccination strategies against meningococcal disease for children under nine years of age in China. Human Vaccines & Immunotherapeutics 20:1.
Read now
Read now
Liv Solvår Nymark, Jacob Dag Berild, Trude Marie Lyngstad, Brita Askeland Winje, Didrik Frimann Vestrheim, Ingeborg Aaberge, Lene Kristine Juvet & Ellen Wolff. (2022) Cost-utility analysis of a universal pneumococcal vaccination programme for older adults in Norway. Human Vaccines & Immunotherapeutics 18:6.
Read now
Read now
Articles from other publishers (3)
Kris Doggen, Albert Jan van Hoek & Jeroen Luyten. (2023) Accounting for Adverse Events Following Immunization in Economic Evaluation: Systematic Review of Economic Evaluations of Pediatric Vaccines Against Pneumococcus, Rotavirus, Human Papillomavirus, Meningococcus and Measles-Mumps-Rubella-Varicella. PharmacoEconomics 41:5, pages 481-497.
Crossref
Crossref
Andrea Conti, Gaia Broglia, Chiara Sacchi, Fabrizia Risi, Francesco Barone-Adesi & Massimiliano Panella. (2023) Efficacy and Safety of Quadrivalent Conjugate Meningococcal Vaccines: A Systematic Review and Meta-Analysis. Vaccines 11:1, pages 178.
Crossref
Crossref
Mark A. Miller & Bradford D. Gessner. 2023. Plotkin's Vaccines. Plotkin's Vaccines
1625
1639.e7
.